FDG PET/CT for tumoral and systemic immune response monitoring of advanced melanoma during first-line combination ipilimumab and nivolumab treatment
| Title: | FDG PET/CT for tumoral and systemic immune response monitoring of advanced melanoma during first-line combination ipilimumab and nivolumab treatment |
|---|---|
| Authors: | Iravani, AmirAff1, Aff2, IDs0025902004815w_cor1; Osman, Medhat M.Aff3; Weppler, Alison M.Aff4; Wallace, RoslynAff4; Galligan, AnnaAff4; Lasocki, ArianAff1, Aff2; Hunter, Morgan O.Aff5; Akhurst, TimAff1, Aff2; Hofman, Michael S.Aff1, Aff2; Lau, Peter K. H.Aff2; Kee, DamienAff2, Aff4; Au-Yeung, GeorgeAff2, Aff4; Sandhu, ShahneenAff2, Aff4; Hicks, Rodney J.Aff1, Aff2 |
| Source: | European Journal of Nuclear Medicine and Molecular Imaging. 47(12):2776-2786 |
| Database: | Springer Nature Journals |